Home › Trial NCT03987087
A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC
- Trial IDNCT03987087
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorGuizhou Medical University
- Enrollment68
- Start date2018-09-01
- ConditionsMalignant Pleural Effusion · Nonsmall Cell Lung Cancer, Stage IV
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.